Condition: Peri-Prosthetic Joint Infection · Sponsor: Aesculap AG
The primary aim of the clinical investigation is to demonstrate the efficacy of a silver-based antimicrobial coating on hip implants in the reduction of periprosthetic infections in revision hip arthroplasty due to periprosthetic infection.
This description comes directly from the study's public registry record.
Lutz Dreyer, Dr. · +49 7461 95 · hiprevision_study@bbraun.com
Britta Wachter, Dr. · +49 746195 · hiprevision_study@bbraun.com
Always discuss trial participation with your own doctor first.
| Charité - Universitätsmedizin Berlin | Berlin, Germany | Recruiting |
| Gruca Orthopedic and Trauma Teaching Hospital, Samodzielny Publiczny Szpital Kliniczny im. prof. Adama Grucy CMKP | Otwock, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06737809